First, we must consider the adverse abdominal effects of GLP-1RA, which include nausea, abdominal distention, constipation, and diarrhea 41,42
Retatrutide is the newest weight loss medication that acts as a triple agonist at GLP-1, GIP, and glucagon receptors
Have a medical-related question you've always wanted answered
What you eat is just as important as how much
We developed this program, in part, based on a review of third-party research suggesting that the dosages used by this program may significantly influence metabolic biomarkers like HbA1c, said Dr
One class of drugs, two systems of care, and a healthcare landscape that is still adjusting to the implications .